Formulation of synthetic vectors for cystic fibrosis gene therapy.
Marshall
John
J
Genzyme Corporation, Framingham, MA, USA.
Cheng
Seng H
SH
D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D003550:Cystic Fibrosis / Q000628:therapy*; D005260:Female; D018014:Gene Transfer Techniques; D017930:Genes, Reporter; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D007477:Ions; D050356:Lipid Metabolism; D008168:Lung / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D010920:Placenta / Q000378:metabolism; D014161:Transduction, Genetic
D007477:Ions; D000469:Alkaline Phosphatase